Sentinel lymph node biopsy followed by lymph node dissection for early cutaneous melanoma
Editorial Group: Cochrane Skin Group
Published Online: 31 JAN 2013
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Kyrgidis A, Tzellos T, Mocellin S, Apalla Z, Lallas A, Pilati P, Stratigos A. Sentinel lymph node biopsy followed by lymph node dissection for early cutaneous melanoma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD010307. DOI: 10.1002/14651858.CD010307.
- Publication Status: Edited (no change to conclusions)
- Published Online: 31 JAN 2013
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects and safety of SLNB and completion lymph node dissection (CLND) for the treatment of early melanoma.
We will also try to elucidate any potential survival advantage of SLNB according to primary tumour thickness to justify the current clinical practice of performing SLNB according to thickness, and we aim to identify baseline factors that may affect rate of recurrence and distant metastasis.